CXCL2 and hepatocellular carcinoma: Another study by Wang et al. revealed that the pseudo serine protease PRSS35 induces CXCL2 degradation, attenuating neutrophil recruitment to tumors and NET formation, ultimately suppressing hepatocellular carcinoma (HCC) progression [130].